The Surgeon

New clinical data from a study of 570 men published in the peer-reviewed Journal of Urology1 support the use of PROGENSA PCA3 as a tool for diagnosing prostate cancer. The study confirms that PROGENSA PCA3, the world’s first gene-based urine test to help detect prostate cancer, can provide clinicians with valuable information that helps guide diagnosis.
(more…)

Related posts

• Scientists pioneer new treatment for prostate cancer (0)
• Vitamin D Inhibits Post-Menopausal Breast Cancer – Clinical Results (0)
• Tiny magnets offer breakthrough in gene therapy for cancer (0)
• Technology To Detect Liver Disease Via Blood Test To Be Developed (0)
• Risk Of Breast Cancer Reduced By Essential Nutrient Found In Eggs (0)